A major breakthrough in the understanding and future control of deadly cholera epidemics
In a report publishing October 17th, 2013 in PLOS Neglected Tropical Diseases, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and its scientific research arm, Epicentre, present results of one of the first-ever, large-scale use of an oral cholera vaccine during a cholera outbreak — a major breakthrough in the understanding and future control of deadly cholera epidemics.
Using results from a mass vaccination campaign of more than 300,000 people conducted in Guinea last year, MSF and Epicentre show the feasibility of implementing a mass vaccination campaign with oral cholera at the onset of an outbreak, similar to the way reactive vaccination campaigns are conducted when diseases such as measles or meningitis are reported in an area.
Last year, MSF teams in Guinea noticed cases of cholera months ahead of the rainy season. These early cholera cases and other factors, including the lack of a cholera epidemic in Guinea for several years, and the ongoing cholera epidemic in neighboring Sierra Leone, were strong indications to MSF and the Ministry of Health that a major cholera epidemic was imminent.
Starting in April of last year the Guinean Ministry of Health and MSF administered 316,250 doses of vaccine during two vaccination rounds in the coastal districts of Boffa and Forecariah, Guinea over six weeks. All individuals older than 12 months were eligible for vaccination in both rounds. The vaccination campaign was well accepted by the local community and MSF achieved high coverage rates. The two doses vaccine coverage was 75.8% in Boffa and 75.9% in Forecariah, respectively. Almost all people surveyed after the campaign, 98.9 percent, reported that they would be vaccinated again in a future cholera campaign.
Oral cholera vaccine was added to the WHO recommendation for cholera treatment in 2010, but so far has not been commonly used as a public health tool for control of the disease. Concerns about its feasibility, timeliness and acceptability by population, as well as fear of diverting resources from other medical programs have discouraged the use of an oral cholera vaccine.
The Latest on: Oral Cholera Vaccine
- Protect the public from bias in automated decision systems on February 21, 2019 at 2:54 pm
Letters are limited to 200 words. State Senate Bill 5527 defines an automated decision system (ADS) as “any algorithm, including one incorporating machine learning or other artificial intelligence tec... […]
- Scholar explores impact of bias in facial-recognition software on February 19, 2019 at 9:52 am
In her short video “The Coded Gaze: Unmasking Algorithmic Bias,” scholar Joy Buolamwini outlines ... he mentioned some of the major challenges of artificial intelligence (AI), including the failure of ... […]
- Deadly US Applications of Artificial Intelligence on February 14, 2019 at 6:44 am
The strategy commits to consider how to handle hacking, bias ... in weapons systems could be overridden or replaced by a much weaker policy. The AI strategy pledges that the Defense Department will on... […]
- Artificial Intelligence Has a Problem With Gender and Racial Bias. Here’s How to Solve It on February 7, 2019 at 4:03 am
These systems are often trained on images of predominantly light-skinned men. And so, I decided to share my experience of the coded gaze, the bias in artificial intelligence that can lead to ... […]
- Novel algorithm can 'de-bias' data for artificial intelligence on January 30, 2019 at 3:27 am
BOSTON: Scientists at MIT have developed an algorithm that can automatically identify and minimise any hidden biases in the data used by artificial intelligence (AI) systems ... algorithm decreased "c... […]
via Google News and Bing News